We conducted a prospective audit of central venous catheter (CVC) use in 1000 consecutive patients to better define the rates of postoperative complications (particularly vascular perforation) and the pattern of CVC and pulmonary artery catheter (PAC) usage (particularly the number of lumens inserted and utilized). Details of CVCs, complications, and the number of lumens in place and used, were recorded daily until all CVCs were removed. A total of 1546 CVCs and 223 PACs were placed in study patients. Two non-fatal perforations occurred: a perforated right atrium in a patient who received an Arrow triple-lumen CVC (previously reported), and a perforated pulmonary artery in a patient upon withdrawal of a Baxter PAC. The risk per patient of any CVC-related perforation was 0.2% (95% confidence interval (CI): 0.02% to 0.7%). The rates of CVC-related sepsis and local infection were 3% (95% CI: 2% to 4%) and 2% (95% CI: 1% to 3%) respectively. At the peak of CVC use (day 1 in the ICU) the overall number of lumens placed was significantly correlated with lumens used (r=0.53), endorsing clinical judgement in the anticipation of the needs of the patient. The modal number of lumen uses in adults and children was four. However, in children, fewer catheters were inserted per patient than in adults (1.28 vs 1.63, P=0.01), and placed lumens were used more intensively (P<0.001). Data appear to justify the routine selection of a triple-lumen CVC in adult patients, but not of a quad-lumen CVC.
Green Lane Hospital (GLH) is a tertiary referral centre specializing in cardiac, thoracic and otorhinolaryngological surgery. The great majority of patients treated in this hospital's Intensive Care Unit (ICU) receive a central venous catheter (CVC) of some kind, and in many instances a flow-directed pulmonary artery catheter (PAC) as well. CVC and PAC use is known to be associated with a variety of complications [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Perforation of the heart or blood vessels is a rare but persistent complication, and is particularly dangerous, especially when it leads to pericardial tamponade. Deaths from this cause continue to be reported [11] [12] [13] [14] [15] [16] , and at least two have occurred in New Zealand within the last decade 17 . The incidence of CVC-related perforation, however, remains poorly defined, and previous estimates from our unit have wide confidence intervals 2, 18 . In addition, the cost of CVCs in a cardiac unit is considerable (e.g., greater than NZ$100,000 per annum at GLH). Quad-lumen CVCs have become popular in recent years, and have advantages in patients who may require several drug infusions in addition to central venous pressure monitoring. However, they are more expensive, have a larger diameter and tend to be stiffer than those with three lumens. Increased catheter diameter has been associated with an increased risk of vascular perforation 19 and multi-lumen catheters (specifically triple-lumen) have been associated with an increased risk of infection 8 . While the choice of CVC must be made on the merits of each case, we know of little information regarding the actual use of CVC lumens in any particular group of patients. Such information is relevant to achieving the best balance between convenience, cost and safety. Therefore, we have conducted a prospective, clinical audit of 1000 patients who received CVCs at GLH.
METHODS
This study was accepted as an audit by the regional ethics committee. One thousand patients who received a CVC on routine clinical grounds were included. The first 203 patients were also part of a prospective, randomized assessment of two CVC types 18 , for which they gave written, informed consent. Data collection was then continued without interruption for a further 797 patients admitted to Green Lane Hospital's ICU on consecutive weekdays.
All 1000 patients were followed from the day of insertion of their first CVC, to the day of removal of their last CVC. A study author visited each patient daily on weekdays to record the patient's location (ICU or ward), the number of CVCs and lumens in place (including PAC lumens) and the date of each CVC insertion and removal. The total number of lumen uses was also recorded on each visit, defined as the total number of monitored pressures, plus the total number of medication and fluid infusions. Thus it was possible for the number of lumen uses to exceed the number of lumens in place if some lumens were used for more than one purpose (e.g., one lumen for two drug infusions). The type of catheter, site of insertion, and any other relevant information was also collected for each CVC. In addition, complications related to the catheter were recorded, including death, perforation, local infection (defined as the presence of local inflammation or discharge), and catheter-related sepsis (defined as a temperature of over 38°C with concurrent positive blood and CVC tip cultures, the same organism being grown from both and with no other apparent source of infection 20 ).
Data analysis was performed with Systat 10 for Windows (SPSS Inc., Chicago, IL, U.S.A.). P values are reported without correction, but to compensate for multiple comparisons, the more conservative level of P≤ 0.01 has been designated as significant.
RESULTS
Of the 1000 patients included in this study, 758 were adults (age ≥12 years) with an average age of 60.2 years (range 13-88 years). The remaining 242 patients were children (age < 12 years), with an average age of 2.1 years (range 0-11 years). Sixty-three per cent of patients were male and 37% were female.
A total of 1546 CVCs were inserted in the 1000 study patients: 1319 (85%) in the internal jugular vein, 113 (7%) in the subclavian, 70 (5%) in the femoral and 11 (1%) in the external jugular vein ( Table 1 ). Of these, 1237 CVCs were inserted in adults and 309 in children (rates of 1.63 and 1.28 catheters per patient respectively-Fisher's exact test, P=0.01). In adult patients 357 (75%) of the 479 catheters placed in addition to the first CVC were PAC sheath introducers ( Table 2 ). In addition, three PAC sheath introducers were placed as the first CVC in adults. Of these 360 introducers, a PAC was placed via 223 (62%)-therefore 38% of the introducers were not used for PAC insertion. No PACs or sheath introducers were used in children. In the course of their hospital stay, 576 (58%) patients received one CVC, 346 (35%) patients received two CVCs, 56 (6%) patients received three CVCs, and more than three CVCs were inserted in 22 (2%) patients. Most CVCs were inserted in the operating room or ICU before the patient proceeded to the hospital ward. However, a further CVC was inserted into each of three adult patients who returned to the ICU on days 4, 5 and 40 of their hospital stay. In addition, a child returned to the ICU twice, on hospital days 14 and 47, and received a CVC on each occasion. The estimated equipment cost of the 1546 CVCs and 223 PACs used in this study was NZ$ 123,806 ( Table 2) .
For all 1000 patients, the median stay in the ICU was one day (range <1 to 41 days). Primary catheters (i.e. the CVC first inserted-A in Table 2 to 18 days). By day 5, 66% of primary catheters had been removed. Secondary catheters (B in Table 2 ) were kept in situ for an average of 3.1 days (median 3, range 1 to 17 days), and 80% had been removed by day 4. The average number of days in situ for any further catheters (C-H) was 6.0 (median 5, range 1 to 18 days). Thirty-nine patients died during the study with a total of 52 (3% of 1546) CVCs in place. No death was considered to be related to the CVC. One thousand and eighty-six (70%) study CVCs were removed when they were no longer needed (Table 3) . Thirty-three (2%) CVCs were removed because it was thought that they had been in situ for too long and should be changed because of the risk of infection. Thirty-six (2%) CVCs were removed because of suspected infection (local or sepsis). In each case these CVCs remained in situ for significantly longer (median 6, range 3 to 12 days) than CVCs removed because they were no longer needed (median 4, range 1 to 18 days Wilcoxon signed-rank test, P=0.001).
Lumen usage
The number of lumens in place and the number of lumens required both peaked on day 1 (in the ICU after surgery). For all 1000 patients, on day 1, the number of lumens placed was significantly correlated with the number of lumens used (Figures 1 and 2 Pearson r=0.53). For adults, on day 1, there was no significant difference between lumens in place and the total number of lumen uses (Figure 1 : modes of 4 vs 4 respectively-Wilcoxon signed-rank test, P=0.7). Sixty-two per cent of adults had four lumens or fewer in place. For children, however, the number of lumens in place was significantly fewer than the number of lumen uses (Figure 2 : modes of 3 vs 4 respectively-Wilcoxon signed-rank test, P<0.001). Ninety-three percent of children had three lumens or fewer in place despite the same modal number of lumen uses (four) as adults.
Complications
The most common postoperative complication was CVC-related sepsis, which occurred in 27 (3%) study patients ( Table 4 ). The second most common complication was local infection, which affected 16 (2%) patients.
Two non-fatal CVC-related perforations occurred in this series. In an adult male patient who received an Arrow triple-lumen CVC (Arrow International Inc., Reading, PA, U.S.A.) by a right subclavian route, a right atrial perforation occurred in which the cause was judged as uncertain, but most probably due to the CVC. This perforation occurred within the first 203 patients, and so has been reported previously 18 . In a second adult male patient who received a Baxter sheath introducer and PAC (Baxter Healthcare Corp., Irvine, CA, U.S.A.) by a right internal jugular route, a perforation of the left pulmonary artery wall occurred as the PAC was withdrawn. The patient was in theatre at the time of the perforation and prompt surgical repair averted any permanent consequences.
The per patient rate for CVC perforation (excluding PACs) was therefore 0.1% (95% CI: 0.003% to 0.6%, n=1000). The rate for PAC perforation calculated for those patients receiving a PAC was 0.4% (95% CI: 0.01% to 2.5%, n=223). The combined risk of CVC perforation (including PACs) per patient was 0.2% (95% CI: 0.02% to 0.7%, n=1000- Table 4 ).
DISCUSSION
Owing to its relatively large sample size, this audit establishes the per patient incidence of a number of CVC-related complications more accurately, with 95% confidence intervals narrower than previous prospective estimates 18 (Table 4 ). The overall estimated risk per patient of catheter-related perforation was 0.2% (or 2 per thousand), with an upper 95% confidence interval of 0.7%. Published estimates of the rate of CVC-related perforation vary widely from 1% to 0.01% (i.e. 1 per 100 to 1 per 10,000) 2, 5, 9, 13, 15, 18, 19, [21] [22] [23] [24] [25] . Our overall rate falls in the middle of this range. The number of patients that need to be studied to obtain accurate estimates of low frequency events is very high. Assuming the present point estimate of 0.2% is correct for the rate of perforation, we would need to study 10,000 patients to achieve a 95% confidence interval of 0.1% to 0.3%. Data collection alone for such a study would take nearly ten years. As one consequence of this requirement for large numbers, our study is not able to quantify the risk in subgroups of CVCs, even though differences may exist. For example, PACs are known to perforate by mechanisms different from those of other CVCs 6, 26, 27 and may carry a higher risk in this regard 28, 29 . However, our observed rate of one pulmonary artery perforation in 223 patients who received a PAC (0.4%, upper 95% CI: 2.5%) is in fact not significantly different from the rate of perforation reported in a large-scale, prospective audit of PAC usage in 6245 patients over 5. 5 intervals are 0.7% and 0.6% respectively), whereas the point estimate is of course doubled. We note that no death has been associated with catheter use in this study, but the above caveats about the need for very large numbers apply. For complications which occur quite frequently (i.e. rates above 1%), studying 1000 patients provides reasonably tight confidence intervals. For example, reviews have estimated that catheter-related infections occur in 1 to 10% of patients 8, 30 -the actual rate being highly dependent on insertion and care technique and the length of time the patient remains catheterized. Our combined rate of local infection and confirmed sepsis falls in the middle of this range (4% with a 95% CI of 3% to 6%- Table 4 ). We have reported elsewhere the rates of arterial puncture, haematoma and arrhythmia during CVC insertion 18 .
It is no longer a standard recommendation to change a CVC on the basis of time alone 8, 30, 31 . Those CVCs removed for suspected infection stayed in significantly longer than those removed because they were no longer needed (median durations of 6 vs 4 days respectively). However, many other CVCs remained in situ for long periods without the development of sepsis, and this finding probably reflects the fact that sicker patients require their CVCs for longer, and also are a subgroup more likely to develop infection.
The use of nine different types of CVC in adults and some 11 more varieties in paediatrics, in addition to PACs (Table 2) , is a high number for a department to keep in stock, and some space and efficiency gains might be achieved by greater standardization. One objective of the audit was to review the selection of CVCs with respect to the number of lumens placed and used, in order to promote more rational practice if possible. It seems likely that the risk of perforation with a CVC increases with its diameter and stiffness (and other factors being equal, increasing the number of lumens in a CVC does increase its diameter and stiffness) 19 . The risk of infection may also be increased by increasing the number of lumens, although this finding seems less secure 32, 33 . Unquestionably, however, increasing the number of lumens in a CVC increases its cost (Table 2) .
Obviously, multiple uses may be made of one lumen, and this occurred in 468 (47%) patients in the present study. Devices such as three-way, or five-way taps 34 can facilitate this, and in very sick patients requiring many infusions and the measurement of multiple pressures, there may be no practical alternative. However the extreme assertion that one lumen would be adequate in all cases does not seem sensible (leaving aside the possible need for a PAC). For adults on day 1, the modal number of lumen uses and lumens placed was four, and there was a reasonable balance between under-and over-utilization. Clinicians, therefore, seem to be selecting lumen number with reasonable predictive accuracy in terms of the needs of the patient, but with a tendency to provide a rather generous number of lumens if multiple uses of some lumens is considered acceptable. While they may be useful in the sickest patients, there seems to be little evidence from these data to support the routine use of a quad-lumen CVC in cardiothoracic and otorhinolaryngologic anaesthesia. With considerable scope for cost savings ( Table 2) , it might seem reasonable, therefore, to routinely place three lumen CVCs. In cardiac anaesthesia, this would permit one lumen for inotropes and vasoconstrictors, one for vasodilators, and one for pressure monitoring and bolus administration, which would be adequate for most patients.
Significantly fewer catheters per patient were inserted in children than in adults (1.28 vs 1.63 respectively), with the number of lumens placed significantly less than the number of lumens used (modes of 3 vs 4 respectively). Far more doublelumen CVCs were used in children than in adults, and only four children received quad-lumen catheters. No PACs were used in children (even though paediatric PACs are available). There was clearly greater pressure on CVC lumens in paediatric patients, with very little underutilization ( Table 2 , and Figures 1 and 2) .
These prospectively collected data provide a useful audit of an important part of clinical practice. There is pressure in many institutions to keep track of so-called performance indicators, and to monitor changes in these over relatively short intervals of time. However, indicators based on high frequency events, collected to monitor efficiency, may in fact be dangerous in the absence of data to show that longerterm safety is not being compromised at the same time. It is very costly and inefficient to injure patients and there is currently widespread concern over iatrogenic harm in healthcare 35 . Safety data is fundamental to progress in the provision of healthcare, and it cannot be obtained casually, or with small numbers. Therefore there is clearly a need for comprehensive, preferably national, prospective monitoring of the serious hazards known to be associated with anaesthetic and intensive care practice. Until such data are available, specific audits such as this one, which examine particular aspects of care in reasonable numbers of patients provide the best index of the risks of practice available to most institutions.
